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Abstract
The cell of origin of the five subtypes (I-V) of germ cell tumors (GCTs) are assumed to be
germ cells from different maturation stages. This is (potentially) reflected in their methylation
status as fetal maturing primordial germ cells are globally demethylated during migration
from the yolk sac to the gonad. Imprinted regions are erased in the gonad and later become
uniparentally imprinted according to fetal sex. Here, 91 GCTs (type I-IV) and four cell lines
were profiled (Illumina’s HumanMethylation450BeadChip). Data was pre-processed con-
trolling for cross hybridization, SNPs, detection rate, probe-type bias and batch effects. The
annotation was extended, covering snRNAs/microRNAs, repeat elements and imprinted re-
gions. A Hidden Markov Model-based genome segmentation was devised to identify differ-
entially methylated genomic regions. Methylation profiles allowed for separation of clusters
of non-seminomas (type II), seminomas/dysgerminomas (type II), spermatocytic semino-
mas (type III) and teratomas/dermoid cysts (type I/IV). The seminomas, dysgerminomas
and spermatocytic seminomas were globally hypomethylated, in line with previous reports
and their demethylated precursor. Differential methylation and imprinting status between
subtypes reflected their presumed cell of origin. Ovarian type I teratomas and dermoid cysts
showed (partial) sex specific uniparental maternal imprinting. The spermatocytic semino-
mas showed uniparental paternal imprinting while testicular teratomas exhibited partial im-
printing erasure. Somatic imprinting in type II GCTs might indicate a cell of origin after
global demethylation but before imprinting erasure. This is earlier than previously described,
but agrees with the totipotent/embryonic stem cell like potential of type II GCTs and their
rare extra-gonadal localization. The results support the common origin of the type I terato-
mas and show strong similarity between ovarian type I teratomas and dermoid cysts. In con-
clusion, we identified specific and global methylation differences between GCT subtypes,
providing insight into their developmental timing and underlying developmental biology.
Data and extended annotation are deposited at GEO (GSE58538 and GPL18809).
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Introduction
During fetal development primordial germ cells (PGC) migrate from the yolk sac, via the hind-
gut to the genital ridge and enter the gonad where they undergo further maturation into the sex
specific lineage, i.e. oogonia for females and spermatogonia for males. During migration and
maturation an epigenetic “reset” takes place. This includes global DNA CpG demethylation dur-
ing the early phases of migration. Specific areas like imprinted regions remain methylated until
the PGCs arrive in the developing gonads where imprinting is subsequently gradually erased.
After these maturing gonadal germ cells reach mitotic (male) or meiotic (female) arrest, de novo
methylation is initiated and uniparental sex specific imprinting is acquired [1–8]. Another infor-
mative marker of developmental stage is X chromosome reactivation which occurs in female
germ cells before the initiation of oogenesis. Studies report varying results regarding the exact
timing of the various steps of the epigenetic reset, i.e. during migration or after arrival in the go-
nads. However, PGCs with an XX chromosomal constitution have been shown to lack X chro-
mosome reactivation if they never reach the gonad [9–12]. For ethical reasons, most of these
data have been experimentally investigated and validated in mice. Even though germ cell devel-
opment differs between mice and men [13], methylation patterns during germ cell development
are reported to be highly similar [14,15].
Germ cell tumors (GCT) originate from germ cells at different developmental stages and are
thought to inherit their methylation profile from their ancestors. The WHO classification sup-
ports five GCT subtypes. Each subtype has specific molecular, clinical and histopathological
properties [16–19]. GCT subtypes have been put in context of normal germ cell development
(Fig 1A) based on gene/microRNA expression, (targeted) epigenetic analysis and genomic con-
stitution as described below and reviewed extensively elsewhere [13,16,17,20–22]. Most of
these studies were targeted at specific genes/genomic regions or concerned a subset of the GCT
subtypes only, most prominently type I or II.
Type I (“infantile”) GCTs manifest clinically as teratoma (TE) and/or yolk sac tumor (YS)
along the migration route of developing PGCs, i.e. the midline of the body. Extra-gonadal, sa-
cral TEs occur most frequently and are mostly benign. Typically these rare tumors (incidence
0.12/100 000) arise before the age of 6 and no Carcinoma In Situ (CIS, see below) is found.
They show global methylation patterns that are reminiscent of their embryonic stem cell
progenitor (i.e. bimodal with modes at0 and100% methylation). These tumors showed
somatic/biparental (50%) imprinting status in earlier studies. Therefore, type I GCTs have
been suggested to originate from PGCs at an early stage, prior to global demethylation and im-
printing erasure [16–18,23–25].
Type II GCTs present most frequently in the gonads and are also called germ cell cancer
(GCC). The incidence of these tumors peaks between 25–35 years of age depending on the sub-
type [16,17,19]}. They comprise1% of all solid cancers in Caucasian males and are responsi-
ble for 60% of all malignancies diagnosed in men between 20 and 40 years with increasing
incidence in the last decades [26] (8.38/100,000 Dutch population. Dutch Caner Registration
(IKNL), www.cijfersoverkanker.nl). Risk factors have been thoroughly investigated and are in-
tegrated in a genvironmental risk model, in which risk is determined by a combination of
micro/macro-environmental and (epi)genetic factors [19,26–32]. A common precursor lesion
called CIS or intratubular germ cell neoplasia unclassified (IGCNU, WHO definition [18]) is
identified for type II GCT [16,17,33,34]. Because of the non-epithelial origin these tumors, CIS
is technically not a proper term but will be used throughout this article in the interest of consis-
tency with existing literature. Type II GCT consist of non-seminomatous (NS) and seminoma-
tous (SE) tumors (Fig 1A), which differ in clinical behavior and molecular profile. SE and
embryonal carcinoma (EC) are the stem cell components of type II GCT and EC can further
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Fig 1. Tumor types/samples and cell lines analyzed and schematic visualization of genomic functional categories of interest. (A)GCT subtypes in
the hypothesized context of normal germ cell development as proposed in earlier studies (grey box). Developmental schemes are indicated in blue (male),
red (female) or when possible in both sexes (white). DG does not originate from CIS but is indicated together with SE for reasons of consistency. (B) Samples
included in this study. Abbreviations match Fig 1A and roman numbers indicate the GCT type to which the histological subtypes belongs. n indicates the
number of tumor samples per group. All samples are frommale patients except the DGs, DCs and a subset of the type I TEs. Please note that when only TE
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differentiate in the other NS subtypes: TE, YS and choriocarcinoma (CH) [16,17]. Type II GCT
originate from maturation arrested, germ line committed PGCs or gonocytes and historically
have been suggested to exhibit erasure of genomic imprinting [13,16–19,22,35]}
Type III, IV and V GCTs originate from more differentiated germ cell progenitor cells.
Type III GCTs are also known as spermatocytic seminoma (SS) and occur solely in the testis.
They arise after the age of 50 and are generally benign and rare (incidence: 0.2/100000). Their
presentation in elderly males, morphology and immunohistochemical profile separates SS
from SE. They originate from germ cells around the spermatogonium stage and are paternally
imprinted [16,36–40]. Type IV tumors are historically hypothesized to originate from a mater-
nally imprinted, committed female germ cell. Type V GCT were excluded from this study be-
cause they show an independent pathogenesis. They originate from the fertilization of an
empty ovum by two sperm cells, resulting in a completely paternally imprinted genomic consti-
tution. This explains their mono-directional lineage of differentiation, unrelated to the germ
cell origin [16–18].
This study aims to identify specific and global differences between the genome-wide methyl-
ation profiles of GCT subtypes. Type I, II, III and IV GCTs and four cell lines representative of
type II GCTs are investigated (Fig 1A and 1B). Differences in methylation profile provides in-
sight into the developmental timing and underlying biology of GCTs. The findings ultimately
relate GCT subtypes to specific stages of (early) developing (embryonic) germ cells. Emphasis
was placed on combining the results with the available literature and on providing extensive ac-
companying data to supply an integrated, hypothesis generating data source for future research.
Results
Methylation differences were investigated, starting from global methylation profiles, followed
by functional enrichment analysis. Probes were functionally classified according to their rela-
tion to genes: transcription regulating (200 or 1500bp upstream of the TSS & 5'UTR) or gene
coding (exon 1, gene body and 3'UTR). Probes covering micro-RNA (MIR) coding regions,
CpG islands and/or transposon elements (LINE/SINE) were classified separately as were im-
printing associated genes. For a detailed explanation, please see Fig 1C and the Materials and
Methods section (section: (Additional) annotation 450K array). After functional enrichment
analysis, specific differentially methylated probes were identified (DMPs). Probes represent in-
dividual CpG sites. Also, differentially methylated regions (DMRs) containing multiple adja-
cent probes were identified. Finally, imprinting status was evaluated. Please note that
differential methylation indicates a statistically significant difference after correction for multi-
ple testing, unless specifically stated otherwise. Differential methylation of ΔM>|0.9| was con-
sidered relevant, in line with the recommendations of Du et al [41]. For details about the
statistical procedures, please see the materials and methods section (analysis protocol). Abbre-
viations are explained in (the legend of) Fig 1.
is denoted, this indicates the group of all type I TEs together. Otherwise II.TE (type II pure TE) or the abbreviations for specific localizations are used as
indicated in this figure. Four GCT cell lines were included; tumor of origin between brackets. (C) Reference to (abbreviations of) the functional genomic
regions as mentioned in the rest of the manuscript. Probes were classified according to their relation to gene coding regions, micro-RNA (MIR) coding
regions, CpG islands and/or transposon elements (LINE/SINE). The distance to the transcription start site (TSS) was used in accordance with the Illumina
manifest: 200 or 1500 bp. Of note, the TSSAssociated category contains all probes with a distance< 1500 bp to the TSS in contrast to the TSS1500 category
from Illumina which is only contains probes 200-1500bp from the TSS. Probes within imprinting associated regions were classified as (1) mapped inside a
known imprinting control region (ICR) or (2) either mapped inside an ICR or mapped close to the TSS of a transcript of an imprinted gene (200/1500bp
upstream, not mutually exclusive). P/M indicates the expressed allele, i.e. paternal/maternal respectively. Numbers between brackets indicate the number of
valid probes within each specific category (total number of valid probes: 437,881). *The visualization did not permit including the probe count for all
categories. The counts for the empty categories are: 5’UTR = 59,338; ISLAND = 136,339; IMPR_P200 = 638; IMPR_P1500 = 1,659; IMPR_M200 = 610;
IMPR_M1500 = 2,265.
doi:10.1371/journal.pone.0122146.g001
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SS and SE/DG show global hypomethylation when compared to EC/
mNS and TE
Fig 2A shows the methylation distributions for all probes, probes associated with the TSS, 3'
UTR, LINES, microRNAs and CpG Islands, respectively. The distributions of the remaining
functional categories are presented in S2A Fig. SS showed global hypomethylation (Fig 2A), i.e. a
large concentration of probes showing a low percentage of methylation and few probes showing
a high methylation percentage. Hypermethylated configurations contain a large concentration
of probes showing a high percentage of methylation and few probes showing a low methylation
percentage. Hypomethylation was also shown in DG and SE samples albeit to a lesser extent, as
can be observed from the mode at 50–60%methylation (Fig 2A). The SE group showed consis-
tent hypomethylation (S2B Fig, page 2), in contrast to study of Nettersheim et al who showed
separate groups of hypo- and hypermethylated SE in a larger sample series [42]. In contrast to
the SE and DG samples, the EC and partly differentiated mNS, type I TE and DC samples con-
sistently showed a bimodal pattern with one mode around 10% and one around 90% (Fig 2A
and Fig 1: relation between subtypes). This bimodal pattern was also observed in three EC cell
lines and a single SE cell line (Fig 2A, CL_SE & CL_EC). In line with previous reports [14,43],
the EC cell lines were more methylated than the SE cell TCam-2 (Fig 2A). The transcription reg-
ulatory region upstream of the TSS (TSSAssociated, TSS200) was generally hypomethylated in
all tumor types as were regions annotated as first exon, 5’UTR and CpG islands. The gene body,
3’-UTR, micro-RNAs and LINE/SINE elements were generally hypermethylated except in SS,
which show a bimodal pattern (Fig 2A and S2A Fig). At these sites, SE/DG showed a median
methylation level of 50% in line with the maximal methylation of their global profile and previ-
ous reports [20,44]. Hypermethylation of LINE/SINE elements NS and hypomethylation (Fig
2A) in SE was in line with a recent genome wide study [20] but contrasted with a targeted study
that showed hypomethylation of 3 specific repetitive elements in both SE and NS [45].
GCT subtypes can be distinguished based on their methylation profile
Principal component analysis (PCA) showed robust separation of homogeneous clusters of EC/
mNS, SE/DG, TE/DC and SS samples when all probes were considered (Fig 2B and S2A Fig). In
line with the larger inter-sample variation (S2B Fig), SE/DG and SS were more scattered in the
PCA plot. Some mNS, which consist partly of differentiated tissue, showed a tendency towards
the differentiated TE/DC group. The type I TE and DC showed an indistinguishable global
methylation profile. Similar observations were made when subsets of probes were considered
that were annotated to specific functional genomic regions (Figs 2B and S2A).
Zooming in: GCT subtype specific methylation patterns
To further pinpoint differences between pairs of GCT subtypes, DMPs were identified
(Table 1, S1 Table), tested for functional and chromosomal enrichment (Fig 3, S3 Fig, Table 1
and S2 Table) and grouped into DMRs (Fig 4, S4 Fig, Table 1, S3 Table, GSE58538: File S1). SE
+ DG and EC + mNS (including type II pure TE) subtypes were merged because of high simi-
larity of the observed methylation profile (Figs 2A and 2B, S3A Fig), in line with literature re-
garding their similar origin [46] and their close relation in the current WHO classification
[16,18]. Recurrent DMRs were identified as genes occurring more than once within or between
comparisons, which may indicate regions of importance (S3 Table, n = 149).
(Differential) methylation of GCT cell lines (4136 DMRs between the cell lines: GSE58538:
File S2) showed little similarity to their in vivo counterparts (Figs 2 and 6, S2 Fig). The cell line
analysis did however identify a biologically relevant DMR previously validated in these cell lines
Unraveling the Origin & Pathogenesis of GCT Using Methylation Profiles
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Fig 2. Methylation patterns in GCT subtypes and cell lines. To illustrate differences in methylation status between histological GCT subtypes two
(visualization) methods were applied. Firstly, the methylation pattern over the whole genome and specific functional categories (Fig 1C) is visualized using
the distribution of the methylation percentage β in all samples of a certain GCT subtype. Next, the discriminatory power of the methylation pattern for each
individual sample is shown using principal component analysis. (A) Distribution of methylation percentage. Violin plots: grey areas indicate a kernel
density plot of the methylation percentage (β) of all probes in all samples in a certain category. The boxplot indicates the interquartile range (black bars) and
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using bisulfite sequencing in [63] (microRNA-371/2/3 cluster, Table 2). 719 gene symbols inter-
sected between tumor and cell line DMRs (S3 Table). The major differences between the sub-
groups of GCT will be summarized hereafter.
Comparing SE/DG, EC/mNS and type I TE. Regardless of their presumed common ori-
gin, EC/mNS and SE/DG showed vastly different methylation profiles. The relative hypermethy-
lation in EC/mNS versus SE/DG was concentrated in regions not involved in transcription
regulation (Fig 3A). This pointed to a global difference in methylation status rather than differ-
ential methylation of specific regulatory elements. This also held for the hypermethylation of
type I TE when compared to SE/DG (Fig 3B). The 61 DMPs hypermethylated in SE/DG relative
to type I TE were concentrated at three specific genes: NCOR2, ALOX12 and ECEL1P2 (Table 1,
S3 Table, S4A Fig).
DMPs between type I TE and EC/mNS indicated a more methylated profile of the EC/mNS
group (Fig 3C). Moreover, the majority of the probes hypermethylated in type I TE were locat-
ed on the X chromosome and can therefore be traced back to hemi-methylation of chromo-
some X in females (TE = male/female, EC/mNS = male only) (Table 1, S3B Fig). DMRs
included many genes involved in male gametogenesis like DMRT3 (Fig 4A). The EC marker
SOX2 [17,64] was present as one of the only 15 hypermethylated autosomal DMRs in type I TE
(Fig 4B). These DMRs presumably relate to the cell of origin as well as to the sex of the patient
(S4B Fig, Table 1 and S3 Table).
Type III (SS) versus type II seminomatous GCT (SE/DG). The general, probes signifi-
cantly hypomethylated in SS as compared to SE/DG were enriched for regions associated with
paternal expression (Fig 3D). DMRs hypermethylated in SE/DG predominantly included re-
current DMRs and DMRs within genes associated with germ cell and testis development
(Table 1 and S3 Table). The promoter of POU5F1 was relatively hypomethylated in SS, while it
is a marker for the stem cell component of type II GCTs and not expressed in SS [17,46,65]
(Fig 4C, discussed in Table 2). DMRs hypermethylated in SS also included genes associated
with male germ cell determination, fertility and GCTs, enforcing the epigenetic relation be-
tween GCT cells and their cell of origin (Table 1 and S3 Table).
Specific GCT associated genes. A number of genes has been associated with (methylation
in) GCTs, both regarding pathogenesis and diagnosis. Table 2 summarizes the literature for
these genes and combines this with the methylation data from this study, e.g. overlap with
DMRs and methylation profile of these genes (see also Fig 5 and S5A Table). A recent meta-
analysis of GCT GWAS studies identified 19 SNPs associated with 13 genes [29]. For most
genes their methylation profile was non discriminative between the GCT subtypes, the excep-
tions being TEX14 which was also independently identified as a DMR[SE/DG-SS] (Fig 4D) and
BAX1, which also contained a DMR[SE/DG-SS] (all SNP related genes: S5B Table).
Imprinting status and X chromosome reactivation
As reviewed in the introduction, gradual and tightly controlled establishment of uniparental
imprinting and X chromosome reactivation (female only) has been demonstrated in develop-
ing germ cells which is at least partly mirrored in their malignant counterparts. Regarding im-
printing controlled regions (Fig 1C and S4 Table) in the tumor groups probes covering regions
median (white squares). X-axis labels indicate histological subgroup according to Fig 1A and 1B. TE indicates type I TE only. (B) Principal Component
Analysis. The first two principal components (PC) are plotted to evaluate the discriminative power of the methylation pattern between the subtypes.
Abbreviations of histological subtypes are explained in Fig 1A. CL indicates cell lines. Please note that in the legend of the PCA the TE group is subdivided
based on gender and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis, o = ovary, m = male, f = female. A more detailed
visualization of the TE classes is provided in S2 Fig, which also includes the full series of 18 functional categories, bootstrap validation of the PCA and an
estimation of the variance explained by the first two principal components.
doi:10.1371/journal.pone.0122146.g002
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Table 1. Pairwise comparison of GCT subtypes.
A. Seminomatous (SE/DG) versus non-seminomatous (EC/mNS) GCTs
DMProbes[SE/DG-EC/MNS] DMProbes[SE/DG-EC/mNS]
6 110,462 (25%)
[no enrichment] # in tr and " in non-tr, LINE/SINE suggested global difference in methylation status
rather than differential methylation of specific regulatory elements. CpG islands were
#. miRs regions were weakly ". ICRs were #, suggesting no difference in imprinting
status.
DMRegions[SE/DG-EC/MNS] DMRegions[SE/DG-EC/mNS]
0 [global]
- [global]
B. Seminomatous type II (SE/DG) versus type I (TE)
DMProbes[SE/DG-TE] DMProbes[SE/DG-TE]
61 56,764 (13%)
significantly overrepresented on chromosome 12 (13/61) and preferentially located in
the 5’UTR of genes and CpG islands
#on tr, CpG islands and ICRs and "of non-trs, transposons and miRs (DMPs[SE/DG-
EC/mNS]).
DMRegions[SE/DG-TE] DMRegions[SE/DG-TE]
3 [global]
NCOR2: (SMRT, silencing mediator for retinoic acid and thyroid hormone receptors)
nuclear receptor co-repressor on 12q24.31 involved in mouse spermatogenesis [47]
and vitamin D metabolism in GCTs [48]. ALOX12: lipoxygenase family [49], has not
implicated in GC(T) biology. ECEL1P2: increased methylation upon aging [50]!
although not implicated in normal/aberrant germ cell development, this might explain
the hypomethylation in pediatric type I TE as compared to adult type II SE/DG. All
three genes were also DMR hotspots.
[global]
C. Non-seminomatous type II (EC/mNS) versus type I (TE)
DMProbes[EC/mNS-TE] DMProbes[EC/MNS-TE]
17,407 1,520
Enrichments were weak, the strongest being # in transposons. 80% on X chromosome! differences in sex (TE = male+female, EC/mNS = male).
" in tr and # in non-tr and transposon elements suggests differential methylation of
specific regulatory elements. " in CpG islands.
DMProbes[EC/mNS-TE] DMRegions[EC/MNS-TE]
580 (all autosomal) 128 (15 autosomal)
e.g. DMRT3: implicated in testis development and male sex determination [46,51]
MOV10L1: which has been implicated in human male infertility [52] and germ cell
maturation in mice [53]. DDR2: crucial for spermatogenesis in mice [54] ICR_P WT1
was also present.
e.g. SOX2: EC marker (see: Table 1). IRX5: germ cell migration in Xenopus laevis
embryos; DMR 1kb downstream of its 3’UTR [55]. MSX1: progression of germ cells
into meiosis, leading to germ cell maturation arrest in mutant embryos; DMR at its
3’UTR [56]. Hypomethylation in type II GCTs [57].
D. Seminomatous type II (SE/DG) versus type III (SS)
DMProbes[SE/DG-SS] DMProbes[SE/DG-SS]
15,340 2,830
" in non-tr and #in the tr. " in ICR_P/IMPR_P200/1500 in line with paternal cell of
origin of SS.
# at non-tr and CpG islands.
DMProbes[SE/DG-SS] DMRegions[SE/DG-SS]
559 30
e.g. hotspot genes like NCOR2, ALOX12, ECL1P2, MSX1 (see above). IRS2:
associated with male germ cell and testis development [58]. POU5F1: SE/DG/EC
marker (Table 1). TEX14: associated with known high risk GCT SNP [29].
SERPINE1 (plasminogen activator inhibitor 1, PAI-1): hypomethylated in GCT except
in SS. PAI-1 SNPs have been associated with poor prognosis in GCTs [59]. The
plasminogen activator system has been implicated in human infertility [60]. MOG:
hypermethylated in SS, knockdown causes male germ cell differentiation in mog
deficient C. Elegans [61,62].
This table concisely summarizes the results of the search for differentially methylated (DM) probes (P) and differentially methylated regions (R) between
pairs (A and B) GCT subtypes. Briefly, the number of DMPs and DMRs is shown separately for probes hypermethylated in A or B. The subtype in which the
probes are hypermethylated is indicated in bold and underlined. Also, a brief interpretation of the genomic function of the DMPs is provided. For the DMRs
the associated genes are discussed in the context of GCTs. (Abbreviations) # significantly underrepresented; " significantly overrepresented; % DMPs is
calculated relative to the total number of valid probes (Materials and Methods section). tr = transcription regulation associated regions (TSS200/
TSSAssociated/5’UTR/EXON1); non-tr = non transcription regulation associated gene coding regions (GENE.BODY/3’UTR). The other functional categories
are depicted in Fig 1C. [global] = global methylation difference between subtypes; no distinguishable potential subtype specific differentially methylated
regulatory elements. (Associated sources) Statistical procedures are described in the Materials and methods section. The overall methylation pattern of
each histological subtype is visualized in Fig 2. Functional enrichment of DMPs is visualized in Fig 3. Details of enrichment calculations and raw counts and
percentages are presented in Table S2. Enrichment of chromosomes is depicted more detailed in S3B Fig. DMRs, recurrent tumor DMR and DMPs are
listed in S3 and S1 Tables respectively. DMRs are visualized in Fig 4, S4 Fig and GSE58538: Files S1 and S2.
doi:10.1371/journal.pone.0122146.t001
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that are regulating paternally expressed genes (ICR_P) showed somatic methylation in type I
and II GCTs with a trend towards hypermethylation in DC (Fig 6A). SS and the cell
lines showed hypomethylation of ICR_Ps, a distinction also visible in the PCA plots. In
IMPR_P200/1500 the pattern of the ICR_P probes seemed to be pooled with a set of unmethy-
lated probes (type I, II, IV GCT) presumably indicating contamination by non-imprinting re-
lated regions and hence not informative for imprinting status (S2A Fig, pages 15 and 16). A
somatic methylation state was shown for ICR_M except in the SS (bimodal) and the CL_SE
(hypomethylated); a difference corroborated by the separation of these groups in the PCA
plot (Fig 6B). IMPR_M200/IMPR_P1500 probes showed hypomethylation similar to non-
imprinted genes in all groups (S2A Fig, pages 18 and 19). No reactivation of chromosome X
was seen in GCTs from female patients, which is reflected by the consistent 50% median meth-
ylation of the X chromosome in these cases (Fig 6C). The cell lines did not reflect the imprint-
ing status of their in vivo counterpart, warranting caution when using the cell lines as a GCT
model system in methylation based experiments.
Methylation status of ICR_Ps and ICR_Ms was similar between individual samples of the
same histology (S2B Fig) with the exception of type I TE and DC (Fig 6D and S2B Fig). In addi-
tion to the earlier analysis, where the type II TEs were grouped with the mNS and the type I
TEs were assessed as one class, TEs were also investigated individually, grouped according to
sex and anatomical site, in line with sex specific imprinting occurring during fetal/germ cell de-
velopment (Fig 6D). The genome-wide methylation pattern was similar for all TEs. No reacti-
vation of chromosome X was seen in the GCTs from female patients. Sacral type I TEs showed
somatic imprinting patterns both in males and females. In line with sex specific imprinting,
ICR_P sites in testicular type I TEs were relatively hypomethylated compared to sacral TEs. In
contrast, ovarian type I TEs showed a tendency towards hypermethylation. Of note, testicular
type I TE also showed a trend towards hypomethylation in ICR_M (only 18 probes). On the
other hand, the expected inverse pattern of ICR_P was seen in the ovarian TEs at the ICR_M
sites. A pattern similar to ovarian type I TE was observed in the individual DC samples: hetero-
geneity and gradual deviation from biparental imprinting towards uniparental maternal im-
printing. Two out of three type II TEs showed a somatic imprinting pattern of both ICR_P
and ICR_M.
Validated ICRs (S4 Table) were also studied individually. After merging overlapping validat-
ed ICRs from literature, 28 unique ICRs remained of which 21 were covered by the 450K array
(4 ICR_M, 16 ICR_P, 1 unknown). ICRs controlling the expression ofH19/IGF2, SNURF/SRPN
andMEST have been studied in GCTs previously (review & results in Table 2). In the ICR_Ps
which constitute the majority of the validated ICRs, the dominating pattern is: (1) somatic
methylation in the type II tumors (2) hypomethylation in the type I testicular TEs and SS and
(3) a trend towards hypermethylation in DC and ovarian TE. (Fig 7A and 7B, S6 Fig).
In summary, ovarian type I TE and DC showed partial sex specific uniparental maternal im-
printing, inverse of the uniparental paternal imprinting of SS. Testicular type I TE shows a
trend towards erasure and type II GCTS (SE/DG/EC/mNS) showed somatic imprinting status.
Discussion
This study provides a detailed overview of the differences in global and local methylation status
between type I-IV GCTs (Fig 1) and relates it to their cell of origin during normal germ cell de-
velopment. Normal germ cell maturation includes complete de- and subsequent remethylation.
Establishment of sex specific uniparental imprinting is physiological as is reactivation of chro-
mosome X in female gametes. The largest methylation differences were detected between the
hypermethylated EC/mNS + type I TE and hypomethylated SS + SE/DG clusters, in line with
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Fig 3. Functional enrichment of DMPs. DMPs were classified according to their functional genomic
location (Fig 1C). Statistical over- and underrepresentation of probes in certain categories provides clues to
differences between GCT subtypes in regarding function of methylation. Enrichment was assessed by
comparing the number of probes in a functional category in a subset of DMPs with the that in the total dataset
(Fisher’s Exact test, see Materials & Methods section). Results are shown for four pairwise (A vs B)
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previous reports [14,43,117,135] (Fig 2A). However, the methylation profiles also allowed for a
more detailed separation of EC/mNS, SE/DG, TE/DC and SS clusters, which is in line with the
differentiation status of the tumors and their cell of origin. This distinction was also apparent
when specific functional genomic regions were evaluated (Fig 2B). Hypermethylation in EC/
mNS and type I TE is concentrated at non-transcription related regions when compared to SE/
DG, pointing to a global difference in methylation status rather than differential methylation
of specific regulatory elements. Moreover, EC/mNS is somewhat more methylated than type I
TE and shows specific differences at transcription regulating genomic regions including genes
implicated in male germ cell development. Regarding type III tumors, differential hypomethy-
lation in SS relative to SE/DG is enriched for paternally expressed imprinting associated re-
gions and DMRs cover male germ cell related genes (Figs 3, 4 and 5, Tables 1 and 2). In
addition, marked differences in imprinting status were observed. Ovarian type I TE and DC
showed partial uniparental maternal imprinting, inverse of the uniparental paternal imprinting
of SS. Testicular type I TE shows a trend towards imprinting erasure and type II GCTS (SE/
DG/EC/mNS) showed somatic imprinting status (Figs 6 and 7). The local and global methyla-
tion difference observed between GCTs could be matched to physiological germ cell develop-
ment, but did not match with their respective cell line models (Fig 8).
Limited knowledge exists about the progenitor of type I tumors. The absence of CIS and
clinically different presentation (pediatric, frequently extra-gonadal, fully differentiated histol-
ogy: TE/YST) sets them apart from the type II tumors [16–18]. Their bimodal global methyla-
tion status could a pattern generally observed in normal differentiated tissues and in very early
germ cell progenitors (pre-migration. Historically type I and II tumors are also thought to be
different with regard to their imprinting status. Imprinting status in these tumors was earlier
shown to be somatic (biparental) or partially erased in case of the type I tumors and erased in
case of the type II GCTs [16]. This positions the progenitor cell of type I tumors before im-
printing erasure in the gonad. Indeed biparental (somatic) imprinting status in extra-gonadal
TE was confirmed in this study and by Amatruda and colleagues [20]. There is a trend towards
imprinting erasure in testicular type I TE. Ovarian type I TE show a trend towards completely
maternal imprinting, but starting from a biparental status (50%), not showing any evidence of
prior complete erasure (Fig 6D). This (partial) mimicking of female germ cells in ovarian type I
TE is in line with in several studies [20,131,132]). However, the non-erased imprinting status,
inactivated X chromosome and generally methylated state fits with the cell of origin at the very
early PGC stage, which is then blocked in physiological complete demethylation, erasure and X
reactivation and, when subjected to a gonadal micro-environment, shows partial erasure/
uniparental imprinting [16–18] (Fig 8).
Most data is available on the epigenetic constitution of the type II tumors, as reviewed be-
fore [13,21]. A strongly hypomethylated state was recently shown for all CIS, the common pre-
cursor of SE and EC [136]. Earlier studies have suggested separated NS-CIS and a SE-CIS types
comparisons of histological subtypes: (A) SE/DG versus EC/mNS; (B) SE/DG vs type I TE; (C) EC/MNS vs
type I TE and (D) SE/DG vs SS. (LEFT) The number (n) of DMPs identified in either the DMP[A-B]
(hypermethylated in A, green) or DMP[A-B] (hypermethylated in B, red) group. (MIDDLE/RIGHT) Functional
enrichment in the DMP[A-B] and DMP[A-B] group respectively. X-axis: positive numbers indicate a
significant overrepresentation of DMPs in a functional category compared to non-DMPs while negative
numbers indicate a significant underrepresentation. Depicted is the log2 ratio of (1) the % of either DMP
group assigned to a category and (2) the % of non-DMPs assigned to that category. Only significant
enrichments are depicted (2-sided Fisher’s Exact test, see Methods section for Bonferroni corrected α
threshold). DMPs[SE/DGvsSS].IMPR_P1500 showed significant underrepresentation, but could not be plotted
on log scale (0 probes in DMP group). Details of calculations and raw counts and percentages are presented
in S2 Table. Y-axis: functional categories as specified in Fig 1C.
doi:10.1371/journal.pone.0122146.g003
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Fig 4. Methylation profile at GCT subtype specific differentially methylated regions (DMRs). Visualization of the methylation percentage at specific loci
is used to zoom in on a predefined region and investigate local methylation differences between GCT subtypes. (A)DMRT3, (B) SOX2, (C) POU5F1 (OCT3/
4), (D) TEX14. (Visualizations) From top to bottom the following is depicted: (1) Four-color heat map indicating methylation % for each individual probe in the
depicted region. For the sample groups specified on the left the median methylation % is shown. (2) Position of all probes in the region of interest (ROI) is
annotated as black rectangles. (3) HMM segments are displayed as grey boxes spanning the segment’s width and grouped per state. Numbers indicate the
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[135], but the lack of methylation in CIS combined with absence of SOX2 (EC marker) expres-
sion [64,136,137] increases the likelihood of a single precursor and progression into SE or NS.
The CIS-like state is evident in the hypomethylated profile of SE/DG as shown in this article
and previous research [14,43,117,135,136]. EC and mNS show a (de novo) methylated profile
(Fig 2A). This is in line with the previously reviewed increased methylation in the transition of
CIS into NS [13,14,43,138], possibly illustrating reversal to a hypermethylated ES like state
[7,16,139–142] or a bimodal methylation state normally present in differentiated tissues as
shown in the differentiated NS. The consistent somatic imprinting pattern in general and at
specific ICRs (Fig 6, S6 Fig and S4 Table) was in line with an earlier report [20] but contrasted
with targeted studies suggesting erased imprinting status at specific ICRs in these tumors using
mainly indirect methods (allele specific expression analysis) and or non-quantitative methyla-
tion analysis (bisulfite specific restriction enzymes) (for review Table 2). The hypomethylated
progenitor and somatic imprinting pattern (Fig 6A and 6B) situates the cell of origin of the
type II tumors possibly earlier than previously described [16]: after global demethylation but
before imprinting erasement, which is also in line with the occurrence of extra-gonadal type II
GCTs (brain, anterior mediastinum) and their totipotent, embryonic stem cell like potential
[16,139–142] (Fig 8).
The other GCT subtypes are historically hypothesized to originate from more mature germ
cell progenitors. Their marker profile has placed the type III tumors at the pre-spermatogoni-
um state with regard to their cell of origin [36–39,46]. Earlier epigenetic data showed a hetero-
geneous profile of histone modification and methylation profiles, not corresponding with a
pre-spermatogonial origin [143]. Our limited series of SS show a consistent pattern of
distinct hypomethylation and loss of imprinting at the paternally expressed ICRs (ICR_M:
heterogeneous 50%, Fig 2B). This matches with a cell of origin between the gonocyte and
spermatogonium stage, after establishment of uniparental imprinting but before initiation of
de novomethylation. The type IV tumors (DC) show a pattern comparable to other differenti-
ated tissues (ovarian type I TE) and show a general trend towards uniparental maternal im-
printing but not starting from a completely erased state, potentially placing their cell of origin
and pathogenesis parallel to the type I ovarian TE and not as a separate entity originating from
a completely maternally imprinted an differentiated female germ cell as described before [16]
(Figs 2B, 6 and 8).
In conclusion this exploratory study of genome wide methylation profiles of GCT subtypes
identified specific and global methylation differences, providing novel insight into the develop-
mental timing and underlying biology of the various subtypes of GCTs and their (embryonic)
cells of origin (Fig 8). Methylation profiles allowed for separation of clusters of NS, SE/DG, SS
and TE/DC, largely in line with the current WHO classification. SE/DG/SS were globally hypo-
methylated, in line with previous reports and the demethylated state of their precursor. Differ-
ential methylation between subtypes reflected the presumed cell of origin as did imprinting
status. However, somatic imprinting in type II GCT might indicate a cell of origin after global
demethylation but before imprinting erasure. This is earlier than previously described, but
agrees with the totipotent/embryonic stem cell like potential of type II GCTs and their rare
extra-gonadal localization. The results support the common origin of the type I TEs and show
strong similarity between ovarian type I TE and DC. However, the limited samples size and
state of each (group of) segment(s). (5) GC%was obtained from the UCSC genome browser database (gc5Base table). (6) Transcripts overlapping with the
ROI are plotted at the bottom. Plot generated using the Gviz package. Abbreviations of histological subtypes are explained in Fig 1A. Please note that the TE
group is subdivided based on gender and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis, o = ovary, m = male,
f = female. CL indicates cell lines.
doi:10.1371/journal.pone.0122146.g004
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Table 2. GCT (methylation) associated genes.
Gene & region Description
APC, chr5 (+), 112,043,195–112,181,936 GCT link: A single study with small sample size (n = 10) showed increase methylation
in most YST as compared to germ cells in normal testis. Expression was high in germ
cells and low in most YSTs [66]. Findings: 2102EP showed mild but significant
relative hypermethylation compared to the other cell lines, but for all tumor groups
APC was consistently hypomethylated.
AR, chr X (+), 66,763,874–66,950,461 GCT link: Androgen receptor methylation can be used as a readout for X inactivation
in non-germ cells. AR was methylated in differentiated NS, but unmethylated in a
proportion of ECs and all SE & SS. This supports the hypothesis that methylation
does not occur in the germ cell lineage [67]. Findings: the promoter region of the AR
was completely deprived of methylation in all male tumors while a certain amount of
methylation (ca. 50%) was present in the female samples. AR contained a DMR only
in the CL where it was relatively methylated in NT2 as compared to all other cell lines
(Fig 5A).
CTA genes GCT link: Cancer Testis Antigens (CTA) are primarily unmethylated in SE. MAGEA1/
3 are predominantly methylated in NS while SYCP1 is unmethylated in NS [68].
MAGEA1: chrX:152,481,522–152,486,116(-), MAGEA3: chrX:151,934,652–
151,938,240(-), SYCP1: chr1:115,397,424–115,537,991(+). Findings: Methylation
differences in these genes were not remarkable except for differential hypomethylation
of TCam-2 and NCCIT compared to the other cell lines. The TSS associated regions
of MAGEA1 and SYCP1 were consistently hypomethylated in SS.
GATA4, chr 8 (+), 11,534,468–11,617,511 GCT link: previously identified DMR between TCam-2 and NCCIT, promoter region
hypermethylated in TCam-2 [69]. Findings: The GATA4 promoter was differentially
hypomethylated in all CL_EC as compared to EC_SE, but this was exactly opposite in
the SE and EC tumor samples. Testicular TEs, like EC/mNS samples showed relative
hypermethylation while sacral/ovarian TEs, DCs and SS showed relative
hypomethylation like the SE/DG samples.
HIC1, chr17 (+), 1,957,448–1,962,981 GCT link: 55% of the GCT show methylation of this area which shows frequent loss
of heterozygosity in somatic adult cancers. 5AZA treatment strongly induced HIC1
expression in non-GCT CLs [70]. HIC1 promoter methylation has been implicated in
treatment resistance in GCTs [71]. Findings: HIC1 was showed predominantly
hypomethylation in all GCT subtypes even though a weak DMR[EC/mNS-TE] was
identified. Of the cell lines, only 2102EP showed differential hypermethylation.
KIT, chr4 (+), 55,524,085–55,606,881 / KITL, chr 12 (-),
88,886,570–88,974,628
GCT link: KIT and KITL regulate primordial germ cell development and homing to the
gonad [72–76]. In the embryonic phase the guidance of KIT+ primordial germ cells
from the hind gut epithelium to the gonads depends strongly on KITL mediated chemo
attraction [75,77–79]. In the postnatal testis KIT-KITL signaling takes place via
paracrine signaling in the germline stem cell niche and is crucial for spermatogenesis
from the spre-matogonial stage onwards [73,75,80,81]. More mature mouse
spermatids and spermatozoa express a c-terminal truncated form of KIT transcribed
from an intronic promotor [82]. Mechanistically, constitutive paracrine / autocrine
activation of KIT/KITL signaling is implicated to be a crucial initiating event for the
malignant transformation of maturation arrested germ cell progenitors [17,19,22]. In
the early stages, KITL positivity is a hallmark of maturation arrested germ cells, CIS
and intratubular SE [17,83–85]. Progression into invasive SE is also strongly related
to KIT/KITL signaling while much less association with the NS phenotype has been
shown [80,86–89]. Activating KIT mutations are identified in ca 13–60% of the SE
(rare in NS) and result in constitutive kinase activity because of ligand independent
dimerization and phosphorylation [90–93]. Recent GWAS studies identified
susceptibility loci for GCTs close to, within or directly related to GCTs [29,94–105]. No
information about KIT or KITL methylation in tumors was presented in literature
although KITL promoter methylation was significantly lower in blood of these patients
[106] and SNPs in KITL combined with aberrations in cAMP regulation were
suggested to contribute to tumor risk in these patients [105]. Findings: KIT (S6A Fig)
and KITL (S6B Fig) were not differentially methylated between any of the tumor
groups or cell lines.
(Continued)
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Table 2. (Continued)
Gene & region Description
miR-371/2/3, chr19 (+): (371) 54,290,929–54,290,995 / (372)
54,290,995–54,291,210 / (373) 54,291,959–54,292,027
GCT link: The micro-371-2-3 cluster is expressed in the stem cell component of GCT
[107] and is a potential diagnostic serum marker for GCT [108]. Upstream of the TSS
of this cluster a DMR has been identified between TCam-2 and NCCIT [69].
Differential methylation in GCT cell lines has been validated using pyrosequencing
and the methylation level showed significant and strong inverse correlation with the
expression of miR-373 (Spearman’s ρ -0.90, p = 0.037) [63]. Findings: The miR-371-
2-3 cluster was hypomethylated in TCam-2 (CL_SE) and 2102EP and
hypermethylated in NT2 and NCCIT (Fig 5B). However, with the exception of SS the
tumors showed hypermethylation of this region, despite known expression in the stem
cell components of type II tumors [63,107].
NANOG, chr12 (+), 7,940,390–7,948,655 GCT link:Specific marker for the all stem cell components of GCTs [17]. RA treatment
of NT2 cells also increased methylation here [109]. Analogous to this CpG sites in the
NANOG promoter (0–306 bp upstream of the TSS) were found hypomethylated in
spermatogonia and hypermethylated in sperm [110]. Findings: The NANOG promoter
region showed a trend towards relative hypomethylation in the undifferentiated stem
cell components of the type II tumors as compared to all other (more differentiated)
GCT subtypes including the type II TE and mNS (intermediate status). However, The
number of probes and consistency of the difference lacked significance (Fig 5C).
POU5F1 (OCT3/4), chr6 (-), 31,132,114–31,148,508 GCT link: Specific marker for the all stem cell components of GCTs [17,65,111].
OCT3/4 transcription is regulated by methylation of conserved regions up to 2.6kb
upstream of the TSS. Another study also showed that little increase of methylation at
specific sites upstream of OCT3/4 strongly inhibited expression [109,112,113].
Differentiation of NT2 after retinoic acid treatment resulted in increased methylation
and loss of expression [109].Findings: A promoter DMR[SE/DG-SS] was identified
despite the fact the SE/DG express the OCT3/4 protein and SS do not [17,46,65] (Fig
4C). However, probes located close to its transcription start site are generally
methylated between 20 and 40% in OCT3/4 positive tumors (SE/EC) which results in
unmethylated alleles primed for expression. Moreover, the promoter region of OCT3/4
showed a non-significant trend towards lower methylation levels in SE/DG and EC/
mNS when compared to the differentiated tumors (TE). Most importantly however,
regulation of OCT3/4 expression is (also) crucially influenced by specific sites more
upstream (ca. 2.6 kb) and a set of distant enhancer [112,113]. Also, we previously
showed that even though high promoter methylation is generally associated with low
expression, this is not always the case [69].
PRSS21, chr16 (+), 2,867,164–2,876,305 GCT link: TESTISIN (PRSS21) is a proposed tumor suppressor gene in TGCT
regulated by methylation of a 385bp long CpG rich island [114] and CpG sites close to
the TSS [115]. Findings: Al GCT subtypes except SS (DMR[SE/DG-SS]) showed
hypermethylation of PRSS21.
RUNX3, chr1 (-), 25,226,002–25,291,612 GCT link: 90% of the infantile YSTs (type I) showed methylation of RUNX3 while
methylation was only rarely observed in the adult GCTs [57,116,117]. Findings: The
promoter region of RUNX3 was consistently hypomentylated, progressing to
hemimethylation on larger distances from the TSS (except SS). RUNX3 only showed
differential methylation between the cell lines, most consistently showing
hypomethylation in NCCIT and hypermethylation in 2102EP.
SOX17, chr8 (+), 55,370,495–55,373,456 GCT link: Discriminative marker between EC (+) and SE (-) [17,64]. Findings: SOX17
was consistently hypomethylated in all tumor groups and cell lines (Fig 5D).
SOX2, chr3 (+), 181,429,712–181,432,224 GCT link: Discriminative marker between EC (+) and SE (-) [17,64]. Previously
identified DMR upstream of TSS between (50%) TCam-2 and (0%) NCCIT [69]
1kb upstream of the SOX2 TSS. The region directly upstream of the SOX2 TSS has
consistently been found hypomethylated in both cell lines [69,118]. TCam-2 has been
shown to differentiate and become SOX2 positive after extra-gonadal injection in mice
[119]. Findings: A region 1 kb upstream of the SOX2 TSS was differentially
hypomethylated in all CL_ECs as compared to TCam-2 (GSE58538: File S2). EC and
SE tumor samples showed consistent hypomethylation of the region -154 –-2283bp
upstream of the SOX2 TSS in contrast to the TE samples which showed higher levels
of methylation (DMR[EC/MNS-TE], Fig 4B).
(Continued)
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Table 2. (Continued)
Gene & region Description
TFAP2C (AP-2γ), chr20 (+), 55,204,358–55,214,339 / TFAP2A
(AP-2α), chr 6 (-), 10,393,419–10,419,892
GCT link:AP-2γ is crucial for progression of PGCs into the germ line [120]. It is a
known germ cell marker, abundantly expressed in CIS and SE, and heterogeneously
expressed in NS and somatic tumors [120,121]. AP-2y expression is induced by
estrogens [122]. Epigenetically, ChIP-seq analysis targeting activating histone marks
showed strong enrichment of AP-2α and AP-2γ motifs in the SE-like cell line TCam-2
[69]. Findings: TFAP2A showed mostly hypomethylation in all tumor groups and cell
lines. Only NCCIT was showed significantly increased methylation at the gene coding
region compared to the other cell lines (GSE58538: File S2). All TE samples showed
a non-significant block of hemimethylated probes close to the TSS of TFAP2A.
TFAP2C was consistently hypomethylated in all tumor groups and cell lines.
XIST, chrX (-), 73,040,486–73,072,588 GCT link: XIST is completely methylated in male somatic cells, in contrast to female
somatic cells. Testicular GCTs show hypomethylation of the 5’ end of XIST which,
have been suggested for TGCT diagnostics [123] but has so far not been validated.
SE/NS/SS showed XIST expression (X inactivation) [67]. Findings: XIST showed no
significant differential methylation in the comparison of the tumor groups or cell lines.
Female gonadal tumors, SE and SS showed a trend towards less methylation as
compared to the strongly methylated profile of the non-seminomatous tumors and
male type I TE.
ICR_M: H19-IGF2, chr11, 2,020,834–2,023,499 GCT link: H19 (M expressed) and IGF2 (P expressed) are inversely controlled by this
ICR upstream of H19 [124]. In mice oocytes are erased at H19 before meiosis while
bialelic methylation occurs before the gonocyte stage in males [125]. In humans H19
is erased in fetal spermatogonia, but becomes fully methylated before meisosis
(spematogonia) [126]. H19 erasure fis unctionally illustrated in [127] and related to
pluripotency markers (SOX2 and OCT3/4) in germ cell development in [128]. Previous
studies using have suggested low methylation of the H19-IFG2 ICR in a variable, but
generally high percentage of the type II GCTs. This has generally been interpreted as
imprinting erasure. Somatic imprinting has been shown in non-gonadal TE and
mimicking of female germ cells has been seen in ovarian TE. Most studies
investigated imprinting indirectly using allele specific expression limiting the sample
sizes because of the mandatory presence of SNPs in this analysis to be informative
[129–132]. But a number of studies inquired the DNA methylation status directly using
bisulfite restriction analysis, identifying consistent demethylation of one allele and
variable methylation of the other in allele specific analysis and low, but not absent
methylation in non-specific analysis [124,133]. Low-somatic imprinting in DG was also
shown by Amatruda and coworkers in a high throughput approach [20]. Findings:
The SS in our series show complete methylation at 1 of the two H19/IFG2 sites
indicating a paternal committed origin. The sacral TEs exhibit mainly a somatic
pattern, presumably indicating a pre-erasure origin. The gonadal I TE/DC show the
lowest level of methylation presumably representing (partial) erasure (I.TE.m.t, TE) or
complete maternal imprinting (I.TE.f.o, DC). Type II GCTs were found to consistently
show somatic imprinting (Fig 7B; 2 regions from literature: S4 Table).
ICR_P: SNURF/SNRPN, chr15, 25,199,934–25,200,343 GCT link: SNURF/SNRPN has been described to show derivation from somatic
imprinting in type II GCTs (non-quantitative, not necessarily indicating erasure) [134].
Low, but not absent methylation in non-allele-specific analysis [124]. Schneider and
colleagues showed absence of the methylated band in bisulfite restriction analysis in
9 dysgerminomas [131]. Findings: In this dataset, this SNURF/SNRPN (controlling
paternal expression) was only covered by a single probe (S6 Fig). This very limited
evidence suggests somatic imprinting in the type II tumors and sacral TE and
uniparental status in the other subtypes: loss of imprinting in the I.TE.m.t and
complete methylation in the ovarian tumors (DC, I.TE.f.o).
ICR_P: MEST, chr7, 130,130,740–130,133,111 GCT link: The MEST ICR regulates paternal expression, is already erased in fetal
spermatogonia and remains so during male germ cell development [126]. Findings:
The imprinting during germ cell development is reflected in our findings: (1)
hypomethylation in the testicular type I TE and SS, (2) somatic imprinting in the type II
tumors, (3) somatic-high imprinting in the ovarian and sacral TE, (4) high methylation
in DC (Fig 7A).
Genomic locations and strand were retrieved from genecards.com/UCSC. Detailed visualizations of the methylation status of these genes is presented in
Fig 5 and S5A Fig. DMRs in the cell lines are presented in GSE58538: File S2. ICRs are visualized in Fig 7 and S6 Fig.
doi:10.1371/journal.pone.0122146.t002
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Fig 5. Methylation profile of GCT specific genes and regions of interest (ROIs). Visualization of the methylation percentage at specific loci is used to
zoom in on a predefined region and investigate local methylation differences between GCT subtypes. The genes are reviewed in Table 2. (A) AR, (B)miR-
371-2-3, (C)NANOG, (D) SOX17. (Visualizations) From top to bottom the following is depicted: (1) Four-color heat map indicating methylation % for each
individual probe in the depicted region. For the sample groups specified on the left the median methylation % is shown. (2) Position of all probes in the region
of interest (ROI) is annotated as black rectangles. (3) HMM segments are displayed as grey boxes spanning the segment’s width and grouped per state.
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conflicting results with some of the current literature warrants careful interpretation of the re-
sults and validation in a larger/extended dataset. Moreover, to interpret the function of differ-
ential methylation between GCT subtypes, targeted validation the findings using matched
expression data or careful evaluation of the effects of methylation in cell line models of GCTs is
a crucial next step, even though validation of a biological relevant and representative DMR in
microRNA-371/2/3 (Table 2) showed excellent match with the results of bisulfite sequencing.
The in-depth review of related literature and extensive accompanying online data (supplemen-
tary and on GEO) serve as a hypothesis generating source for future research.
Materials and Methods
Samples
Patient samples. Use of tissue samples remaining after diagnosis for scientific reasons was
approved by Medical Ethical Committee (MEC) of the Erasmus MC Rotterdam (The Nether-
lands), permission 02.981. This included the permission to use the secondary tissue without
further consent. Samples were used according to the “Code for Proper Secondary Use of
Human Tissue in The Netherlands” developed by the Dutch Federation of Medical Scientific
Societies (FMWV (Version 2002, update 2011)). An overview of the samples in this study is
presented in Fig 1A and 1B. Samples were collected when submitted to the pathology depart-
ment and stored in liquid nitrogen.
Cell lines. Four cell lines were included (Fig 1B), all modelling type II GCTs. Cell lines de-
rived from EC (CL_EC) include NT2[144–148], NCCIT [145,149] and 2102EP[144–148]. TCam-
2 closely resembles SE (CL_SE) [150–152]. TCam-2 was grown in RPMI1640 (#61870–010,
Thermo Fisher Scientific / Life Technologies, Carlsbad, CA, USA). 2102EP and NCCIT were
grown in DMEM/F12 (#12634–010, Thermo Fisher Scientific / Life Technologies). NT2 was
grown in DMEM high glucose (#31966–021, Thermo Fisher Scientific / Life Technologies). All
cell lines were cultured in T75 cm2 flasks to 75–90% confluence, each with the addition of 10%
Fetal Calf Serum (#CH30160.03, FCS, GE Healthcare Life Sciences, HyClone Laboratories, Utah,
USA) and 1/100 Penicillin/Streptomycin (#15140, Thermo Fisher Scientific / Life Technologies).
Methylation profiling
DNA was isolated as described in [110]. The GCT material used contained> 75% tumor cells.
Bisulfite conversion and methylation detection was performed using Illumina’s HumanMethy-
lation450 BeadChip (450K array) and exported as described in [69]. This array does not distin-
guish between DNAmethylation variants like 5mC and 5hmC [153].
Data analysis
Data (pre-)processing. Further processing was carried out in R using the LUMI package
[154] according to [155,156]. In the raw data, no structural differences in quality or batch ef-
fects were observed. Poorly performing probes (detection p<0.01 in> 95% of the samples),
cross hybridizing probes and probes with a SNP at or within 10 bp of the target CpG (allele
frequency> = 0.05) were excluded [156]. As a result 44,540 probes were discarded, leaving
437,881 valid, methylation related probes for processing and analysis. Finally, color
Numbers indicate the state of each (group of) segment(s). (5) GC%was obtained from the UCSC genome browser database (gc5Base table). (6) Transcripts
overlapping with the ROI are plotted at the bottom. Plot generated using the Gviz package. Abbreviations of histological subtypes are explained in Fig 1A.
Please note that the TE group is subdivided based on gender and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis,
o = ovary, m = male, f = female. CL indicates cell lines.
doi:10.1371/journal.pone.0122146.g005
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Fig 6. Methylation of imprinting control regions and the X chromosome. Analogous to Fig 2 the differences in methylation status between histological
GCT subtypes is illustrated by two methods. Firstly, the methylation pattern is visualized using the distribution of the methylation percentage β. Next, the
discriminatory power of the methylation pattern for each individual sample is shown using principal component analysis. (A) All probes associated with
paternally expressed genes (ICR_P). (B) All probes associated with maternally expressed genes (ICR_M). (C) All probes located on the X chromosome. (D)
Distribution of methylation in individual TE samples ordered by sex and localization. To compare type I and II TE the n = 3 type II pure TEs from the mNS
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adjustment, quantile normalization and BMIQ-based correction for probe type bias (Infinium
I vs II) were performed [154,155,157]. Data processing resulted in two quantifications of a
CpG site’s methylation status: the methylation percentage β and an associated M-value which
(logit2(β)). M-values were used for statistical computations because of a more favorable
were included in this visualization. Methylation levels of all probes, and probes associated with ICRs (P/M) and probes on the X chromosome are
subsequently shown. (Distribution plots of methylation percentage.) Violin plots: grey areas indicate a kernel density plot of the methylation percentage
(β) of all probes in all samples in a certain category. The boxplot indicates the interquartile range (black bars) and median (white squares). X-axis labels
indicate histological subgroup according to Fig 1A and 1B. TE indicates type I TE only. (Principal Component Analysis.) The first two principal components
(PC) are plotted to evaluate the discriminative power of the methylation pattern between the subtypes. Abbreviations of histological subtypes are explained in
Fig 1A. CL indicates cell lines. Please note that in the legend of the PCA the TE group is subdivided based on gender and localization: I = type I; II = type II/
formally part of the mNS group, s = sacrum, t = testis, o = ovary, m = male, f = female.
doi:10.1371/journal.pone.0122146.g006
Fig 7. Methylation status of imprinting control regions. Visualization of the methylation percentage at specific loci is used to zoom in on a predefined
region and investigate local imprinting differences between GCT subtypes. Two illustrative regions are depicted. (A) ICR_P:MEST. (B) ICR_M: H19-IGF2.
The overlappingH19 transcript is an aberrant, long alternative transcript (H19-012, ENST00000428066). This ICR regulatesH19 and IGF2 expression and
lies upstream all other transcripts of H19. The other ICRs are visualized in S6 Fig and listed in S4 Table. (Visualizations) From top to bottom the following is
depicted: (1) Four-color heat map indicating methylation % for each individual probe in the depicted region. For the sample groups specified on the left the
median methylation % is shown. (2) Position of all probes in the region of interest (ROI) is annotated as black rectangles. (3) HMM segments are displayed as
grey boxes spanning the segment’s width and grouped per state. Numbers indicate the state of each (group of) segment(s). (5) GC%was obtained from the
UCSC genome browser database (gc5Base table). (6) Transcripts overlapping with the ROI are plotted at the bottom. Plot generated using the Gviz
package. Abbreviations of histological subtypes are explained in Fig 1A. Please note that the TE group is subdivided based on gender and localization:
I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis, o = ovary, m = male, f = female. CL indicates cell lines.
doi:10.1371/journal.pone.0122146.g007
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tradeoff between true positive rate and detection rate [41]. All data is available via GEO
(GSE58538).
(Additional) annotation 450K array.. The 450K annotation manifest (v1.2) as supplied
by Illumina contains a number of functional genomic classes like a probe’s association with
CpG islands, gene coding regions, etc. The manifest was extended with (additional) functional
genomic classes, based on the GRch37/hg19 assembly. Briefly, probes close to small nuclear
RNAs and microRNAs from snoRNABase and miRBase were identified, as were probes within
repeats defined by RepeatMasker (source: UCSC). Probes close to the transcription start site
(TSS) of imprinted genes were also identified (geneimprint.com / igc.otago.ac.nz). Known im-
printing control regions (ICR) and their association with either paternal or maternal expres-
sion were retrieved fromWAMIDEX and igc.otago.ac.nz. Imprinting is indicated using the
Fig 8. GCTmethylation status in context of methylation during germ cell development. The top and bottom line charts depict normal germ cell
development in female and male respectively (stages specified in the middle black bar). Methylation status during normal germ cell development is depicted
for the global genome, ICRs and chromosome X (see Discussion). Putative cells of origin of the various types of GCTs are indicated in the brown boxes.
ICR_P/M = ICR regulating paternally/maternally expressed genes. Bimodal indicates a methylation pattern peaking 0 and 100% with the exception of SE/DG
(between 0 and50). The table (bottom) provides a summary of the results, mainly Figs 2 and 6. Abbreviations: pf = primordial follicle. Type I tumors are
indicated with their type (I), sex (m = male, f = female) and location (s = sacral, t = testis, o = ovary). Other GCT subtypes are indicated with their type (I, II, IV)
and the abbreviation of each histological class, which are explained in the main text. Gradient bars indicate percentages of methylation (0!100%, green-
white-grey-red) analogous to the gradient used in the other figures.
doi:10.1371/journal.pone.0122146.g008
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expressed allele. Illumina probe classes were extended with a number of merged categories.
Where applicable, the upstream (-) and downstream (+) margins reported in this manuscript
are analogous to the Illumina annotation (-1500+0; -200+0). The eighteen functional categories
of primary interest to this manuscript are illustrated in Fig 1C. The extended annotation in-
cluding its documentation is available at GEO (GPL18809).
Analysis protocol. Below, the subsequent steps of the data analysis are described. More
details are presented in S1 Fig. Depending on the context, “feature” can refer to a probe or a
segment. All results are based on the GRch37/hg19 assembly.
Global methylation: Violin plots were created per histological subtype using all (global) or
functional subsets of 450K probes. Violin plots (vioplot package) integrate the benefits of a
boxplot and a kernel density plot. Two-dimensional principal component analysis (PCA) was
applied and validated using bootstrapping to assess how well the methylation values of (subsets
of) the probes separated the histological subtypes. Formal statistical testing of the distribution
of the methylation values identified (small) significant differences between almost all tumor
classes (data not shown, Kruskal Wallis test followed by pairwise, Benjamini-Hochberg cor-
rected MannWhitney U tests). The PCA and violin plot based approach was preferred/used to
identify the largest, most relevant differences.
Defining genomic segments and discriminative methylation states: To detect regions of in-
terest rather than only selecting individual differentiating probes (CpG sites) a HMMwas
trained on the tumor samples. Without a priori information about tumor type, the Hidden Mar-
kov Model (HMM) combines adjacent probes into segments and assigns these segments to k
mutually exclusive states, each with distinct methylation profiles over all tumor samples. k = 20
was used as the likelihood of the model saturated around this number of states (S1 Fig, page 11).
In total, 133,730 segments were identified. The median methylation value (M or β) of all probes
in a segment or state was taken as methylation proxy. As a proof of concept, S1 Fig (page 17)
shows clear separation of male and female samples based on state 15 which almost exclusively
contains probes on the X chromosome. The result of the HMM is included in the GEO submis-
sion of the data (GSE58538) and its properties/procedures are summarized in S1 Fig.
Differentiating features (probes or segments): Features showing low variability over all sam-
ples were excluded before formally testing for differential methylation (σM,probes<0.8, n = 77,154/
437,881 (17,62%) & σM,segments<0.6, n = 13,229/133,730 (9,89%), S1 Fig, page 8). A MannWhit-
ney U test was applied to each feature, comparing the distribution of M values between two histo-
logical subtypes. If significant (p<0.05, Benjamini-Hochberg corrected [158]), the subtype
specificity was validated in 100 stratified bootstrap samples. If the feature proved to be significant
in95% of the validation samples and showed a difference in medianM values> |0.9| between
the pair of histological subtypes it was considered potentially discriminating. The value of 0.9 was
chosen as the mean of the cut-off range recommended by Du and coworkers (0.4–1.4) [41]. Al-
though a less stringent setting might result in a higher detection rate, it will considerably reduce
the true positive rate [41]. The sign of the difference in median M value was used to assign a rela-
tive methylation status (hyper/hypo) in either of the two subtypes under pairwise consideration.
Differentiating Hidden Markov Model (HMM) states: To identify non-adjacent regions that
showed similar patterns of methylation a logistic LASSO regression model was fitted on the M
values of the HMM states (glmnet packgage) [159]. Coefficients> 0 were selected from the
most regularized regression model within 1 standard deviation of the model with minimal cross
validation error. A 10 fold cross validated λ was used. Features included in the selected state(s)
and showing a difference in median M values> |0.9| (see above) between the pair of histological
subtypes compared were considered potentially discriminating. The sign of the difference in me-
dian M value was used to assign a relative methylation status (hyper-/hypomethylated) in each
of the subtypes.
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Final selection of differentially methylated probes (DMPs): Features of interest were identified
in the intersection of (1) all probes in discriminating states, (2) all probes in discriminating seg-
ments and (3) all individually discriminating probes (S1 Fig (p. 3/5), also see above). This was done
separately for probes that showed relative hypermethylation in either of the subtypes under pair-
wise comparison. This way, two groups of differentially methylated probes (DMPs) were identified,
showing relative hypermethylation in one subtype and relative hypomethylation in the other.
Functional enrichment: The sets of DMPs were subjected to enrichment analysis for 18
functional categories (Fig 1C) using a two sided Fisher’s Exact test. Analogously, association
with chromosome and state was tested. p<0.05/(18+24+20) = 0.00080645161 was considered
significant, hence retaining a Bonferroni corrected Type I error rate of 5% (18 functional cate-
gories, 24 chromosomes, 20 states).
Differentially methylated regions (DMRs): Regions with 5 adjacent DMPs and a maxi-
mal inter-DMP distance 1 kb were identified as DMRs between the tumor groups. Annota-
tions were retrieved for DMRs including flanking regions of 20% of the length of each DMR.
Analysis of the cell lines: Cell lines were compared to tumor samples in the evaluation of
specific regions of interest in the tumor samples and with regard to their global methylation
profile. Moreover, they were analyzed using the DMRforPairs package to identify specific
DMR in these unique samples ([160], using the default settings except min_dM = 0.9, see
above). For the NCCIT and TCam-2 cell lines this analysis matches the one performed in [69].
Software. Analyses were performed in R 3.1.0/Bioconductor 2.14 (Windows 7 x64) and
2.15.2/Bioconductor 2.11 (Redhat Linux x64). Additional R packages: parallel & gplots. The
HMMwas trained using Matlab R2012a (64 bits) using the MOGHMM toolbox.
Supporting Information
S1 Fig. Supplementary methods. A detailed flowchart and description of the analysis protocol
is presented, followed by a visual illustration of the selection of differentially methylated fea-
tures. The motivation for the threshold when filtering low variability probes is presented next.
Finally, the properties of the Hidden Markov Model (HMM) are presented together with a de-
tailed description of is construction. HMM state 15 is presented as a proof of concept, discrimi-
nating between male and female samples based on X-chomosomal localization of the large
majority of the probes in this class.
(PDF)
S2 Fig. A, Methylation patterns in GCT subtypes and cell lines—All categories and valida-
tion. In addition to the selected categories presented in Fig 2 this figure contains all 18 functional
categories presented in Fig 1C and includes the primary PCA as well as an its validation (i.e. ro-
bustness of the result). PCA was performed on the total dataset (left) and validated using strati-
fied bootstrapping (middle: training, right: validation). (Distribution plot of methylation
percentage) Violin plots: grey areas indicate a kernel density plot of the methylation percentage
(β) of all probes in all samples in a certain category. The boxplot indicates the interquartile range
(black bars) and median (white squares). X-axis labels indicate histological subgroup according
to Fig 1A and 1B. TE indicates type I TE only. (Principal Component Analysis) The first two
principal components (PC) are plotted to evaluate the discriminative power of the methylation
pattern between the subtypes. Abbreviations of histological subtypes are explained in Fig 1A. CL
indicates cell lines. Please note that in the legend of the PCA the TE group is subdivided based
on gender and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum,
t = testis, o = ovary, m = male, f = female. S2B Fig, Methylation patterns in GCT subtypes and
cell lines—Global methylation patterns in individual samples. X-axis indicates arbitrary sample
ID. The sex of the patient from which the sample originates is indicated in blue (male) or red
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(female). Density plots are explained in the legend of Fig 2. Distributions are shown for all
probes individual per sample. The ICR_P and ICR_M categories are presented separately to fa-
cilitate the discussion about imprinting. The red dashed line indicates somatic imprinting (50%).
Please note that details on the TE group are presented in the main text (Fig 6D) and that this cat-
egory is therefore omitted here. This also holds for the n = 3 type II pure TE included in the
mNS group. (Distribution plot of methylation percentage) Violin plots: grey areas indicate a ker-
nel density plot of the methylation percentage (β) of all probes in all samples in a certain catego-
ry. The boxplot indicates the interquartile range (black bars) and median (white squares). X-axis
labels indicate histological subgroup according to Fig 1A and 1B. TE indicates type I TE only.
(PDF)
S3 Fig. A, Enrichment of differentially methylated probes (DMPs) for chromosomal posi-
tion and HMM state—Merged GCT subtypes in pairwise comparisons. The SE+DG and EC-
+mNS categories were merged because of high similarity in biological classification and
methylation profile. Despite their similarities, the DC and type I TE because they belong to
different histological classes. S3B Fig, Enrichment of differentially methylated probes (DMPs)
for chromosomal position and HMM state—Association between DMPs and chromosome /
HMM state. Stacked bar charts indicate the fraction of probes in a subset (DMP[A-B], DMP
[A-B], non-DMP) that is mapped to a specific chromosome or assigned to a specific state. Grey
indicates the non-DMPs and red and green indicated the DMPs hypermethylated in the sub-
type with the matching color in the figure (alternating green/white = A, alternating red/
white = B).  = significant over-/underrepresentation of DMPs relative to the non-DMP subset
(tested per chromosome/state, 2-sided Fisher’s exact test, see Methods for Bonferroni corrected
α threshold). In the right bottom of each figure the coefficients of the LASSO regression model
are depicted. These roughly match the strongest over- and underrepresentations identified by
the Fisher’s Exact tests on the states. The LASSO selected states are marked orange in the table
indicating the significant associations between each state and either DMP group.
(PDF)
S4 Fig. A, Methylation profile at GCT subtype specific differentially methylated regions
(DMRs)—continued—SE/DG versus type I TE. This figure depicts the DMRs between GCT
subtypes discussed in the main text in addition to those already visualized in Fig 4. (Visualiza-
tions) From top to bottom the following is depicted: (1) Four-color heat map indicating methyl-
ation % for each individual probe in the depicted region. For the sample groups specified on the
left the median methylation % is shown. (2) Position of all probes in the region of interest (ROI)
is annotated as black rectangles. (3) HMM segments are displayed as grey boxes spanning the
segment’s width and grouped per state. Numbers indicate the state of each (group of) segment
(s). (5) GC% was obtained from the UCSC genome browser database (gc5Base table). (6) Tran-
scripts overlapping with the ROI are plotted at the bottom. Plot generated using the Gviz pack-
age. Abbreviations of histological subtypes are explained in Fig 1A. Please note that the TE
group is subdivided based on gender and localization: I = type I; II = type II/formally part of the
mNS group, s = sacrum, t = testis, o = ovary, m = male, f = female. CL indicates cell lines. S4B
Fig, Methylation profile at GCT subtype specific differentially methylated regions (DMRs)—
continued—EC/mNS versus type I TE. This figure depicts the DMRs between GCT subtypes
discussed in the main text in addition to those already visualized in Fig 4. (Visualizations) From
top to bottom the following is depicted: (1) Four-color heat map indicating methylation % for
each individual probe in the depicted region. For the sample groups specified on the left the
median methylation % is shown. (2) Position of all probes in the region of interest (ROI) is an-
notated as black rectangles. (3) HMM segments are displayed as grey boxes spanning the seg-
ment’s width and grouped per state. Numbers indicate the state of each (group of) segment(s).
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(5) GC% was obtained from the UCSC genome browser database (gc5Base table). (6) Tran-
scripts overlapping with the ROI are plotted at the bottom. Plot generated using the Gviz pack-
age. Abbreviations of histological subtypes are explained in Fig 1A. Please note that the TE
group is subdivided based on gender and localization: I = type I; II = type II/formally part of the
mNS group, s = sacrum, t = testis, o = ovary, m = male, f = female. CL indicates cell lines. S4C
Fig. Methylation profile at GCT subtype specific differentially methylated regions (DMRs)—
continued—SE/DG versus SS. This figure depicts the DMRs between GCT subtypes discussed
in the main text in addition to those already visualized in Fig 4. (Visualizations) From top to
bottom the following is depicted: (1) Four-color heat map indicating methylation % for each in-
dividual probe in the depicted region. For the sample groups specified on the left the median
methylation % is shown. (2) Position of all probes in the region of interest (ROI) is annotated as
black rectangles. (3) HMM segments are displayed as grey boxes spanning the segment’s width
and grouped per state. Numbers indicate the state of each (group of) segment(s). (5) GC% was
obtained from the UCSC genome browser database (gc5Base table). (6) Transcripts overlapping
with the ROI are plotted at the bottom. Plot generated using the Gviz package. Abbreviations of
histological subtypes are explained in Fig 1A. Please note that the TE group is subdivided based
on gender and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum,
t = testis, o = ovary, m = male, f = female. CL indicates cell lines.
(PDF)
S5 Fig. A, Methylation status of GCT specific genes. This figure (together with S5B Fig) de-
picts the genes discussed in the main text and Table 2 in addition to those already visualized in
Fig 5. Genes are annotated 1.5kb upstream of their TSS and 1.5kb downstream of their tran-
scription termination site. (Visualizations) From top to bottom the following is depicted: (1)
Four-color heat map indicating methylation % for each individual probe in the depicted region.
For the sample groups specified on the left the median methylation % is shown. (2) Position of
all probes in the region of interest (ROI) is annotated as black rectangles. (3) HMM segments
are displayed as grey boxes spanning the segment’s width and grouped per state. Numbers indi-
cate the state of each (group of) segment(s). (5) GC% was obtained from the UCSC genome
browser database (gc5Base table). (6) Transcripts overlapping with the ROI are plotted at the
bottom. Plot generated using the Gviz package. Abbreviations of histological subtypes are ex-
plained in Fig 1A. Please note that the TE group is subdivided based on gender and localiza-
tion: I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis, o = ovary,
m = male, f = female. CL indicates cell lines. S5B Fig. Methylation status of genes with SNPs
significantly associated with GCTs. This figure (together with S5A Fig) depicts the genes dis-
cussed in the main text and Table 2 in addition to those already visualized in Fig 5. Genes are
annotated 1.5kb upstream of their TSS and 1.5kb downstream of their transcription termina-
tion site. (Visualizations) From top to bottom the following is depicted: (1) Four-color heat
map indicating methylation % for each individual probe in the depicted region. For the sample
groups specified on the left the median methylation % is shown. (2) Position of all probes in
the region of interest (ROI) is annotated as black rectangles. (3) HMM segments are displayed
as grey boxes spanning the segment’s width and grouped per state. Numbers indicate the state
of each (group of) segment(s). (5) GC% was obtained from the UCSC genome browser data-
base (gc5Base table). (6) Transcripts overlapping with the ROI are plotted at the bottom. Plot
generated using the Gviz package. Abbreviations of histological subtypes are explained in
Fig 1A. Please note that the TE group is subdivided based on gender and localization: I = type
I; II = type II/formally part of the mNS group, s = sacrum, t = testis, o = ovary, m = male,
f = female. CL indicates cell lines.
(PDF)
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S6 Fig. Methylation status of known imprinting control regions (ICRs). ICRs identified as
described in the materials and methods sections were checked for coverage on the 450K array.
21/28 unique ICRs were covered by one or more probes. These were visualized here (overview:
S4 Table).H19_IGF2 regions: the overlapping transcript is an aberrant, long alternative tran-
script (H19-012, ENST00000428066). These ICRs regulatesH19 and IGF2 expression and lie
upstream all other transcripts of H19. (Visualizations) From top to bottom the following is de-
picted: (1) Four-color heat map indicating methylation % for each individual probe in the de-
picted region. For the sample groups specified on the left the median methylation % is shown.
(2) Position of all probes in the region of interest (ROI) is annotated as black rectangles. (3)
HMM segments are displayed as grey boxes spanning the segment’s width and grouped per
state. Numbers indicate the state of each (group of) segment(s). (5) GC% was obtained from
the UCSC genome browser database (gc5Base table). (6) Transcripts overlapping with the ROI
are plotted at the bottom. Plot generated using the Gviz package. Abbreviations of histological
subtypes are explained in Fig 1A. Please note that the TE group is subdivided based on gender
and localization: I = type I; II = type II/formally part of the mNS group, s = sacrum, t = testis,
o = ovary, m = male, f = female. CL indicates cell lines.
(PDF)
S1 Table. List of DMPs resulting from pairwise comparison of GCT subtypes.
(XLSX)
S2 Table. Counts, percentages, log scores and statistical test results for enrichment in func-
tional genomic categories. (A) SE/DG vs EC/mNS; (B) SE/DG vs type I TE; (C) EC/mNS vs
type I TE; (D) SE/DG vs SS. Rows indicate the functional categories. Columns indicate the
number of probes in the non-DMP and both subtype specific DMP sets. Next, the fraction (%)
of this count relative to all non-DMPs or either set of DMPs is presented. The log-scores are
calculated as log2(%DMP/%non-DMPs) and visually presented in Fig 3 for those categories
showing significant over-/underrepresentation. Significance of the enrichment was evaluated
using a two-sided Fisher Exact test with a Bonferroni corrected α threshold as specified in the
Materials & Methods section.
(XLSX)
S3 Table. (DMRs between tumor groups). List of DMRs for each pair of GCT subtypes. (Re-
current tumor DMRs) Gene symbols that occurred in more than one DMR; either irrespective
of DMR subset (n.total.occurences) or in multiple independent DMR subsets (n.dmr.lists)
(Overlap tumor and CL DMRs) Gene symbols involved in DMRs identified between both the
tumor groups and the cell lines. The second column indicates in which tumor comparisons the
gene symbol was involved in a DMR.
(XLSX)
S4 Table. Merged known ICRs from literature with sources. Also see S6 Fig for a visual re-
presentation of the methylation status at the ICRs if covered by the 450K array (21/28).
(CSV)
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